Literature DB >> 28283605

Baseline Hemodynamic Impairment and Future Stroke Risk in Adult Idiopathic Moyamoya Phenomenon: Results of a Prospective Natural History Study.

Colin P Derdeyn1, Gregory J Zipfel2, Allyson R Zazulia2, Patricia H Davis2, Shyam Prabhakaran2, Cristina S Ivan2, Venkatesh Aiyagari2, James R Sagar2, Nancy Hantler2, Lina Shinawi2, John J Lee2, Hussain Jafri2, Robert L Grubb2, J Philip Miller2, Ralph G Dacey2.   

Abstract

BACKGROUND AND
PURPOSE: The purpose was to test the hypothesis that increased oxygen extraction fraction (OEF), a marker of severe hemodynamic impairment measured by positron emission tomography, is an independent risk factor for subsequent ischemic stroke in this population.
METHODS: Adults with idiopathic moyamoya phenomena were recruited between 2005 and 2012 for a prospective, multicenter, blindly adjudicated, longitudinal cohort study. Measurements of OEF were obtained on enrollment. Subjects were followed up for the occurrence of ipsilateral ischemic stroke at 6-month intervals. Patients were censored at the time of surgical revascularization or at last follow-up. The primary analysis was time to ischemic stroke in the territory of the occlusive vasculopathy.
RESULTS: Forty-nine subjects were followed up during a median of 3.7 years. One of 16 patients with increased OEF on enrollment had an ischemic stroke and another had an intraparenchymal hemorrhage. Three of 33 patients with normal OEF had an ischemic stroke. On a per-hemisphere basis, 21 of 79 hemispheres with moyamoya vasculopathy had increased OEF at baseline. No ischemic strokes and one hemorrhage occurred in a hemisphere with increased OEF (n=21). Sixteen patients (20 hemispheres), including 5 with increased OEF at enrollment, were censored at a mean of 5.3 months after enrollment for revascularization surgery.
CONCLUSIONS: The risk of new or recurrent stroke was lower than expected. The low event rate, low prevalence of increased OEF, and potential selection bias introduced by revascularization surgery limit strong conclusions about the association of increased OEF and future stroke risk. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00629915.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  arterial occlusive disease; atherosclerosis; natural history

Mesh:

Substances:

Year:  2017        PMID: 28283605      PMCID: PMC8204377          DOI: 10.1161/STROKEAHA.116.014538

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  27 in total

1.  Moyamoya disease in Washington State and California.

Authors:  Ken Uchino; S Claiborne Johnston; Kyra J Becker; David L Tirschwell
Journal:  Neurology       Date:  2005-09-27       Impact factor: 9.910

2.  Significance of increased oxygen extraction fraction in five-year prognosis of major cerebral arterial occlusive diseases.

Authors:  H Yamauchi; H Fukuyama; Y Nagahama; H Nabatame; M Ueno; S Nishizawa; J Konishi; H Shio
Journal:  J Nucl Med       Date:  1999-12       Impact factor: 10.057

3.  Clinical features and outcome in North American adults with moyamoya phenomenon.

Authors:  Christopher L Hallemeier; Keith M Rich; Robert L Grubb; Michael R Chicoine; Christopher J Moran; DeWitte T Cross; Gregory J Zipfel; Ralph G Dacey; Colin P Derdeyn
Journal:  Stroke       Date:  2006-04-27       Impact factor: 7.914

4.  If nothing goes wrong, is everything all right? Interpreting zero numerators.

Authors:  J A Hanley; A Lippman-Hand
Journal:  JAMA       Date:  1983-04-01       Impact factor: 56.272

5.  Verifying the stroke-free phenotype by structured telephone interview.

Authors:  J F Meschia; T G Brott; F E Chukwudelunzu; J Hardy; R D Brown; I Meissner; L J Hall; E J Atkinson; P C O'Brien
Journal:  Stroke       Date:  2000-05       Impact factor: 7.914

6.  Comparison of PET oxygen extraction fraction methods for the prediction of stroke risk.

Authors:  C P Derdeyn; T O Videen; R L Grubb; W J Powers
Journal:  J Nucl Med       Date:  2001-08       Impact factor: 10.057

Review 7.  Moyamoya disease and moyamoya syndrome.

Authors:  R Michael Scott; Edward R Smith
Journal:  N Engl J Med       Date:  2009-03-19       Impact factor: 91.245

8.  Moyamoya disease in Europeans.

Authors:  Markus Kraemer; Wilhelm Heienbrok; Peter Berlit
Journal:  Stroke       Date:  2008-09-11       Impact factor: 7.914

9.  Hemodynamic effects of middle cerebral artery stenosis and occlusion.

Authors:  C P Derdeyn; W J Powers; R L Grubb
Journal:  AJNR Am J Neuroradiol       Date:  1998-09       Impact factor: 3.825

10.  Importance of hemodynamic factors in the prognosis of symptomatic carotid occlusion.

Authors:  R L Grubb; C P Derdeyn; S M Fritsch; D A Carpenter; K D Yundt; T O Videen; E L Spitznagel; W J Powers
Journal:  JAMA       Date:  1998 Sep 23-30       Impact factor: 56.272

View more
  9 in total

Review 1.  Hemodynamics and oxygen extraction in chronic large artery steno-occlusive disease: Clinical applications for predicting stroke risk.

Authors:  Colin P Derdeyn
Journal:  J Cereb Blood Flow Metab       Date:  2017-09-19       Impact factor: 6.200

2.  Spatial coefficient of variation of arterial spin labeling MRI for detecting hemodynamic disturbances measured with 15O-gas PET in patients with moyamoya disease.

Authors:  Shoko Hara; Yoji Tanaka; Motoki Inaji; Shihori Hayashi; Kenji Ishii; Tadashi Nariai; Taketoshi Maehara
Journal:  Neuroradiology       Date:  2021-09-09       Impact factor: 2.804

3.  Vessel Wall and Lumen Features in North American Moyamoya Patients.

Authors:  Petrice M Cogswell; Sarah K Lants; L Taylor Davis; Meher R Juttukonda; Matthew R Fusco; Manus J Donahue
Journal:  Clin Neuroradiol       Date:  2019-08-06       Impact factor: 3.649

4.  Hemodynamic Impairment Measured by Positron-Emission Tomography Is Regionally Associated with Decreased Cortical Thickness in Moyamoya Phenomenon.

Authors:  J J Lee; J S Shimony; H Jafri; A R Zazulia; R G Dacey; G R Zipfel; C P Derdeyn
Journal:  AJNR Am J Neuroradiol       Date:  2018-10-25       Impact factor: 3.825

5.  A Prospective, Longitudinal Magnetic Resonance Imaging Evaluation of Cerebrovascular Reactivity and Infarct Development in Patients With Intracranial Stenosis.

Authors:  Meher R Juttukonda; Larry T Davis; Sarah K Lants; Spencer L Waddle; Chelsea A Lee; Niral J Patel; Lori C Jordan; Manus J Donahue
Journal:  J Magn Reson Imaging       Date:  2021-03-24       Impact factor: 5.119

6.  Predictors of clinical or cerebral lesion progression in adult moyamoya angiopathy.

Authors:  Dominique Hervé; Nathanaelle Ibos-Augé; Lionel Calvière; Christina Rogan; Marc Antoine Labeyrie; Jean Pierre Guichard; Ophélia Godin; Manoelle Kossorotoff; Marie Odile Habert; Elisabeth Tournier Lasserve; Sylvie Chevret; Hugues Chabriat
Journal:  Neurology       Date:  2019-06-25       Impact factor: 9.910

7.  Digital subtraction angiographic characteristics of progression of moyamoya disease 6 months prior to surgical revascularisation.

Authors:  Peicong Ge; Qian Zhang; Xun Ye; Xingju Liu; Xiaofeng Deng; Jia Wang; Rong Wang; Yan Zhang; Dong Zhang; Ji Zong Zhao
Journal:  Stroke Vasc Neurol       Date:  2020-02-27

Review 8.  A critical appraisal of bypass surgery in moyamoya disease.

Authors:  Michael Moussouttas; Igor Rybinnik
Journal:  Ther Adv Neurol Disord       Date:  2020-05-26       Impact factor: 6.570

9.  Multimodal evaluation of the cerebrovascular reserve in Neurofibromatosis type 1 patients with Moyamoya syndrome.

Authors:  Alessandra D'Amico; Lorenzo Ugga; Sirio Cocozza; Sara Maria Delle Acque Giorgio; Domenico Cicala; Claudia Santoro; Daniela Melis; Giuseppe Cinalli; Arturo Brunetti; Sabina Pappatà
Journal:  Neurol Sci       Date:  2020-07-10       Impact factor: 3.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.